10/1
08:18 am
ophly
Shattuck plunges after discontinuing lead candidate [Seeking Alpha]
Low
Report
Shattuck plunges after discontinuing lead candidate [Seeking Alpha]
8/15
06:02 pm
ophly
U.S. Food and Drug Administration Accepts for Priority Review Deciphera's New Drug Application for Vimseltinib for the Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT) [Yahoo! Finance]
Low
Report
U.S. Food and Drug Administration Accepts for Priority Review Deciphera's New Drug Application for Vimseltinib for the Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT) [Yahoo! Finance]